| 产品名称： | Histoplasma capsulatum Darling |
|---|---|
| 商品货号： | TS205407 |
| Deposited As： | Histoplasma capsulatum Darling, anamorph |
| Strain Designations： | 6624 ATCC 28307, CDC A811 |
| Alternate State： | Ajellomyces capsulatus (Kwon-Chung) McGinnis et Katz, teleomorph |
| Application： | Biomedical Research and Development Material Emerging infectious disease research Respiratory research |
| Biosafety Level： | 3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | human lymphocyte blastogenesis mycelial and yeast forms CF Reactivity uric acid in ecology of Histoplasma capsulatum uptake of sulfur-containing compounds method for isolation GC content maintenance of mycelial phase differentiation of Histoplasma capsulatum and H. duboisii fluorescent antibody studies Serotypes differentiation from other pathogens Chitinase re antigenicity enzymatic hydrolysis Antigens inhibition by rabbit alveolar macrophage lysosomal extract |
| Medium： | ATCC® Medium 906: Pine and Drouhets Histoplasma yeast-phase medium |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | L Pine |
| Chain of Custody： | ATCC < |
| Isolation： | sputum, Ohio |
| References： | Ehrhard HB, Pine L. Factors influencing the production of H and M antigens by Histoplasma capsulatum: development and evaluation of a shake culture procedure. Appl. Microbiol. 23: 236-249, 1972. PubMed: 4622821 Ehrhard HB, Pine L. Factors influencing the production of H and M antigens by Histoplasma capsulatum: effect of physical factors and composition of medium. Appl. Microbiol. 23: 250-261, 1972. PubMed: 4622822 Bawdon RE, et al. Deoxyribonucleic acid base composition of the yeastlike and mycelial phases of Histoplasma capsulatum and Blastomyces dermatitidis. J. Bacteriol. 111: 593-596, 1972. PubMed: 5053471 Pine L, et al. Studies on the thermal degradation of the H and M antigens of lyophilized histoplasmin. Sabouraudia 19: 55-70, 1981. PubMed: 6164105 Alford RH, Cartwright BB. Human lymphocyte blastogenesis induced by living and dead Histoplasma capsulatum yeasts and soluble yeast autolysate. Sabouraudia 19: 85-95, 1981. PubMed: 7256491 Calderone RA, Peterson E. Inhibition of amino acid uptake and incorporation into Histoplasma capsulatum by a lysosomal extract from rabbit alveolar macrophages. J. Reticuloendothel. Soc. 26: 11-19, 1979. PubMed: 490508 Reiss E. Serial enzymatic hydrolysis of cell walls of two serotypes of yeast- form Histoplasma capsulatum with alpha(1 leads to 3)-glucanase, beta(1 leads to 3)-glucanase, pronase, and chitinase. Infect. Immun. 16: 181-188, 1977. PubMed: 873605 Kaufman L, Kaplan W. Preparation of a fluorescent antibody specific for the yeast phase of Histoplasma capsulatum. J. Bacteriol. 82: 729-735, 1961. PubMed: 14454457 Kaufman L, Brandt B. Fluorescent-antibody studies of the mycelial form of Histoplasma capsulatum and morphologically similar fungi . J. Bacteriol. 87: 120-126, 1964. PubMed: 14102844 Garrison RG, Gordon L. A concentration and cultural method for the enhanced isolation of Histoplasma capsulatum from sputum. Health Lab. Sci. 8: 231-237, 1971. PubMed: 5115118 . . Contrib. Microbiol. Immunol. 3: 138-168, 1977. Pine L. Growth of Histoplasma capsulatum. VI. Maintenance of the mycelial phase. Appl. Microbiol. 19: 413-420, 1970. PubMed: 5440171 Pine L. Growth on amino acids, cell wall proteins, and hydrolysis of yeast phase cell walls of Histoplasma capsulatum and H. duboisii. Sabouraudia 10: 244-255, 1972. PubMed: 4640042 Odds FC, et al. Effect of chitinase complex on the antigenicity and chemistry of yeast- form cell walls and other fractions of Histoplasma capsulatum and Blastomyces dermatitidis. Sabouraudia 12: 138-149, 1974. PubMed: 4604380 Li M, et al. Complement fixing cross reactivity between Histoplasma capsulatum and certain form-related aleuriosporic Hyphomycetes. Mycopathol. Mycol. Appl. 33: 353-363, 1967. PubMed: 4967884 Lockwood GF, Garrison RG. The possibel role of uric acid in the ecology of Histoplasma capsulatum. Mycopathol. Mycol. Appl. 35: 377-388, 1968. PubMed: 5696730 Garrison RG, et al. The uptake of low molecular weight sulfur-containing compounds by Histoplasma capsulatum and related dimorphic fungi. Mycopathol. Mycol. Appl. 40: 171-180, 1970. PubMed: 5455792 Kaufman L, Blumer S. Occurrence of serotypes among Histoplasma capsulatum strains. J. Bacteriol. 91: 1434-1439, 1966. PubMed: 5326107 Kaufman L, Blumer S. Development and use of a polyvalent conjugate to differentiate Histoplasma capsulatum and Histoplasma duboisii from other pathogens. J. Bacteriol. 95: 1243-1246, 1968. PubMed: 4869210 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Histoplasma capsulatum Darling |
|---|---|
| 商品货号： | TS205407 |
| Deposited As： | Histoplasma capsulatum Darling, anamorph |
| Strain Designations： | 6624 ATCC 28307, CDC A811 |
| Alternate State： | Ajellomyces capsulatus (Kwon-Chung) McGinnis et Katz, teleomorph |
| Application： | Biomedical Research and Development Material Emerging infectious disease research Respiratory research |
| Biosafety Level： | 3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | human lymphocyte blastogenesis mycelial and yeast forms CF Reactivity uric acid in ecology of Histoplasma capsulatum uptake of sulfur-containing compounds method for isolation GC content maintenance of mycelial phase differentiation of Histoplasma capsulatum and H. duboisii fluorescent antibody studies Serotypes differentiation from other pathogens Chitinase re antigenicity enzymatic hydrolysis Antigens inhibition by rabbit alveolar macrophage lysosomal extract |
| Medium： | ATCC® Medium 906: Pine and Drouhets Histoplasma yeast-phase medium |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | L Pine |
| Chain of Custody： | ATCC < |
| Isolation： | sputum, Ohio |
| References： | Ehrhard HB, Pine L. Factors influencing the production of H and M antigens by Histoplasma capsulatum: development and evaluation of a shake culture procedure. Appl. Microbiol. 23: 236-249, 1972. PubMed: 4622821 Ehrhard HB, Pine L. Factors influencing the production of H and M antigens by Histoplasma capsulatum: effect of physical factors and composition of medium. Appl. Microbiol. 23: 250-261, 1972. PubMed: 4622822 Bawdon RE, et al. Deoxyribonucleic acid base composition of the yeastlike and mycelial phases of Histoplasma capsulatum and Blastomyces dermatitidis. J. Bacteriol. 111: 593-596, 1972. PubMed: 5053471 Pine L, et al. Studies on the thermal degradation of the H and M antigens of lyophilized histoplasmin. Sabouraudia 19: 55-70, 1981. PubMed: 6164105 Alford RH, Cartwright BB. Human lymphocyte blastogenesis induced by living and dead Histoplasma capsulatum yeasts and soluble yeast autolysate. Sabouraudia 19: 85-95, 1981. PubMed: 7256491 Calderone RA, Peterson E. Inhibition of amino acid uptake and incorporation into Histoplasma capsulatum by a lysosomal extract from rabbit alveolar macrophages. J. Reticuloendothel. Soc. 26: 11-19, 1979. PubMed: 490508 Reiss E. Serial enzymatic hydrolysis of cell walls of two serotypes of yeast- form Histoplasma capsulatum with alpha(1 leads to 3)-glucanase, beta(1 leads to 3)-glucanase, pronase, and chitinase. Infect. Immun. 16: 181-188, 1977. PubMed: 873605 Kaufman L, Kaplan W. Preparation of a fluorescent antibody specific for the yeast phase of Histoplasma capsulatum. J. Bacteriol. 82: 729-735, 1961. PubMed: 14454457 Kaufman L, Brandt B. Fluorescent-antibody studies of the mycelial form of Histoplasma capsulatum and morphologically similar fungi . J. Bacteriol. 87: 120-126, 1964. PubMed: 14102844 Garrison RG, Gordon L. A concentration and cultural method for the enhanced isolation of Histoplasma capsulatum from sputum. Health Lab. Sci. 8: 231-237, 1971. PubMed: 5115118 . . Contrib. Microbiol. Immunol. 3: 138-168, 1977. Pine L. Growth of Histoplasma capsulatum. VI. Maintenance of the mycelial phase. Appl. Microbiol. 19: 413-420, 1970. PubMed: 5440171 Pine L. Growth on amino acids, cell wall proteins, and hydrolysis of yeast phase cell walls of Histoplasma capsulatum and H. duboisii. Sabouraudia 10: 244-255, 1972. PubMed: 4640042 Odds FC, et al. Effect of chitinase complex on the antigenicity and chemistry of yeast- form cell walls and other fractions of Histoplasma capsulatum and Blastomyces dermatitidis. Sabouraudia 12: 138-149, 1974. PubMed: 4604380 Li M, et al. Complement fixing cross reactivity between Histoplasma capsulatum and certain form-related aleuriosporic Hyphomycetes. Mycopathol. Mycol. Appl. 33: 353-363, 1967. PubMed: 4967884 Lockwood GF, Garrison RG. The possibel role of uric acid in the ecology of Histoplasma capsulatum. Mycopathol. Mycol. Appl. 35: 377-388, 1968. PubMed: 5696730 Garrison RG, et al. The uptake of low molecular weight sulfur-containing compounds by Histoplasma capsulatum and related dimorphic fungi. Mycopathol. Mycol. Appl. 40: 171-180, 1970. PubMed: 5455792 Kaufman L, Blumer S. Occurrence of serotypes among Histoplasma capsulatum strains. J. Bacteriol. 91: 1434-1439, 1966. PubMed: 5326107 Kaufman L, Blumer S. Development and use of a polyvalent conjugate to differentiate Histoplasma capsulatum and Histoplasma duboisii from other pathogens. J. Bacteriol. 95: 1243-1246, 1968. PubMed: 4869210 |
